For research use only. Not for therapeutic Use.
Pumafentrine is a dual inhibitor of PDE3 and PDE4.
Catalog Number | I035211 |
CAS Number | 207993-12-2 |
Synonyms | Pumafentrine; BY343; BYK 33043; BY-343; BYK33043; |
Molecular Formula | C29H39N3O3 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 4-((4aR,10bS)-9-ethoxy-8-methoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin-6-yl)-N,N-diisopropylbenzamide |
InChI | InChI=1S/C29H39N3O3/c1-8-35-27-15-22-23(16-26(27)34-7)28(30-25-13-14-31(6)17-24(22)25)20-9-11-21(12-10-20)29(33)32(18(2)3)19(4)5/h9-12,15-16,18-19,24-25H,8,13-14,17H2,1-7H3/t24-,25-/m1/s1 |
InChIKey | CVDXFPBVOIERBH-JWQCQUIFSA-N |
SMILES | O=C(N(C(C)C)C(C)C)C1=CC=C(C2=N[C@]3([H])CCN(C)C[C@]3([H])C4=CC(OCC)=C(OC)C=C24)C=C1 |
Reference | 1: Page CP. Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol. 2014;165(3):152-64. doi: 10.1159/000368800. Epub 2014 Dec 20. Review. PubMed PMID: 25532037. |